Education
About Us
Working with TipRanks
Follow Us
Voyageur Pharmaceuticals (TSE:VM)
:VM
Total Valuation
Voyageur Pharmaceuticals has a market cap or net worth of $28.10M. The enterprise value is C$6.97M.
Market Cap$28.10M
Enterprise ValueC$6.97M
Share Statistics
Voyageur Pharmaceuticals has 160,552,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding160,552,860
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Voyageur Pharmaceuticals’s return on equity (ROE) is -3.79 and return on invested capital (ROIC) is -337.19%.
Return on Equity (ROE)-3.79
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-337.19%
Return on Capital Employed (ROCE)-3.37
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.02
Valuation Ratios
The current PE Ratio of Voyageur Pharmaceuticals is -5.24. Voyageur Pharmaceuticals’s PEG ratio is -0.33.
PE Ratio-5.24
PS Ratio0.00
PB Ratio19.88
Price to Fair Value19.88
Price to FCF-29.59
Price to Operating Cash Flow-29.59
PEG Ratio-0.33
Income Statement
In the last 12 months, Voyageur Pharmaceuticals had revenue of 0.00 and earned -1.71M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-1.57K
Operating Income-1.70M
Pretax Income-1.71M
Net Income-1.71M
EBITDA-1.71M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.50M and capital expenditures -38.10K, giving a free cash flow of -1.54M billion.
Operating Cash Flow-1.50M
Free Cash Flow-1.54M
Free Cash Flow per Share>-0.01
Dividends & Yields
Voyageur Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.14
52-Week Price Change210.00%
50-Day Moving Average0.17
200-Day Moving Average0.11
Relative Strength Index (RSI)48.90
Average Volume (3m)125.11K
Important Dates
Voyageur Pharmaceuticals upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateApr 25, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend Date―
Financial Position
Voyageur Pharmaceuticals as a current ratio of 0.17, with Debt / Equity ratio of 3.37%
Current Ratio0.17
Quick Ratio0.14
Debt to Market Cap<0.01
Net Debt to EBITDA0.07
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Voyageur Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Voyageur Pharmaceuticals EV to EBITDA ratio is -5.17, with an EV/FCF ratio of -29.18.
EV to Sales0.00
EV to EBITDA-5.17
EV to Free Cash Flow-29.18
EV to Operating Cash Flow-29.18
Balance Sheet
Voyageur Pharmaceuticals has $638.99K in cash and marketable securities with C$40.00K in debt, giving a net cash position of -$598.99K billion.
Cash & Marketable Securities$638.99K
Total DebtC$40.00K
Net Cash-$598.99K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Voyageur Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―